Exane Asset Management’s CVS Health CVS Stock Holding History

Exane Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-610	Closed	-$37.9K	–	136
2018 Q1	$37.9K	Buy	+610	New	+$43.8K	0.01%	120

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Asset Management's CVS Position: Q2 2018 in Review

Exane Asset Management sold out of CVS Health (CVS) in Q2 2018, closing a stake of 610 shares — an estimated $37.9K sold.

Exane Asset Management first reported a position in CVS in Q1 2018 and held it in 1 quarter. The position peaked at $37.9K in Q1 2018. 1,572 funds tracked by Wall St. Rank hold CVS as of Q2 2018.

Exane Asset Management reported no remaining CVS Health position as of Q2 2018 after selling out during the quarter.
Exane Asset Management sold 610 CVS Health shares in Q2 2018, an estimated $37.9K.
Exane Asset Management first reported a position in CVS Health in Q1 2018 and held it in 1 quarter.
Exane Asset Management's CVS Health position peaked at $37.9K in Q1 2018.
1,572 funds tracked by Wall St. Rank held CVS Health as of Q2 2018.

Based on Exane Asset Management's 13F filing for Q2 2018, filed 6 Sep 2018.